Login

The Investor on Tour - Q&A with Francis Van Eeckhout, CEO Deceuninck | Francis Van Eeckhout - CEO of Deceuninck 00:10:00

Share On Facebook Share On Twitter

Francis Van Eeckhout is Chairman/Interim CEO at Deceuninck.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Getech: Expert Solutions for Energy Asset Management and Environmental Responsibility
00:10:00
Navigating Investment Opportunities Amid Rising Rates
00:10:00
Anthony Chukumba, managing director at Loop Capital, discusses GameStop's new CEO, who hails from Amazon, on 'Closing Bell'.
00:10:00
Kevin Ford serves as the President and CEO of Calian Group Ltd., driving its strategic direction and growth initiatives
00:10:00
Jean Michel Ng Tseung, New CEO of MCB Group, Shares Vision for a Sustainable Future | Jean Michel Ng Tseung , CEO , MCB Group Ltd.
00:10:00
Planning Ahead: Mid-Quarter Market Insights from FCMA | Foresight Capital Management Advisors – Fiduciary Financial Experts
00:10:00
Simon Alderman Millar Account Director EMEA at Darktrace Keynote | Poppy Gustafsson, CEO, Darktrace PLCDARK:LSE
00:10:00
Mid-Year Financial Check-In: Aligning with Your Mission Statement Using the Integrity Report
00:10:00
I encountered issues accessing the Comparably website. However, based on available information from other sources, HTC Corp's company culture is generally rated as average, with a focus on innovation but challenges in leadership and employee satisfaction.
00:10:00
Horizonte Minerals: Advancing Nickel Projects in Brazil
00:10:00
G Mining Ventures: Advancing TZ Gold Project Towards 2024 Production
00:10:00
John Connaughton on Long-Term Strategies and Market Dislocation | John Connaughton, Co-Managing Partner ,  Bain Capital .

© 2017 - Neuhu+